600529 Stock Overview
Manufactures and sells pharmaceutical glass packaging and butyl rubber series products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 6/6 |
Rewards
Risk Analysis
No risks detected for 600529 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Shandong Pharmaceutical Glass Co.Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥27.72 |
| 52 Week High | CN¥32.33 |
| 52 Week Low | CN¥21.61 |
| Beta | 0.43 |
| 1 Month Change | 9.74% |
| 3 Month Change | 10.75% |
| 1 Year Change | 11.50% |
| 3 Year Change | -30.61% |
| 5 Year Change | 0.40% |
| Change since IPO | 816.84% |
Recent News & Updates
Recent updates
There Is A Reason Shandong Pharmaceutical Glass Co.Ltd's (SHSE:600529) Price Is Undemanding
Dec 13
Returns On Capital At Shandong Pharmaceutical GlassLtd (SHSE:600529) Have Hit The Brakes
Aug 25Calculating The Fair Value Of Shandong Pharmaceutical Glass Co.Ltd (SHSE:600529)
May 31The Returns At Shandong Pharmaceutical GlassLtd (SHSE:600529) Aren't Growing
May 13Shandong Pharmaceutical Glass Co.Ltd Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next
Apr 26Shareholder Returns
| 600529 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 6.9% | -2.8% | -1.2% |
| 1Y | 11.5% | -9.2% | 11.8% |
Return vs Industry: 600529 exceeded the CN Medical Equipment industry which returned -9.2% over the past year.
Return vs Market: 600529 matched the CN Market which returned 11.8% over the past year.
Price Volatility
| 600529 volatility | |
|---|---|
| 600529 Average Weekly Movement | 4.6% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600529 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600529's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 6,473 | Jun Zhang | www.pharmglass.com |
Shandong Pharmaceutical Glass Co Ltd manufactures and sells pharmaceutical glass packaging and butyl rubber series products in China. It offers pharma glass packaging products, such as molded injection glass vials, food-grade bottles, clear cosmetic bottles, cobalt blue and green bottles, tubular glass vials, ampoules, glass tubing products, amber glass bottles, and other borosilicate glass products; butyl rubber stoppers; prefilled syringes, plastic and aluminum caps, plastic caps, and plastic bottles; and dropper caps and Teflon coated rubber stoppers.
Shandong Pharmaceutical Glass Co.Ltd Fundamentals Summary
| 600529 fundamental statistics | |
|---|---|
| Market cap | CN¥18.40b |
| Earnings (TTM) | CN¥882.00m |
| Revenue (TTM) | CN¥5.13b |
20.9x
P/E Ratio3.6x
P/S RatioIs 600529 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600529 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.13b |
| Cost of Revenue | CN¥3.58b |
| Gross Profit | CN¥1.56b |
| Other Expenses | CN¥673.46m |
| Earnings | CN¥882.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.33 |
| Gross Margin | 30.30% |
| Net Profit Margin | 17.18% |
| Debt/Equity Ratio | 0% |
How did 600529 perform over the long term?
See historical performance and comparisonDividends
2.2%
Current Dividend Yield53%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 00:31 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shandong Pharmaceutical Glass Co.Ltd is covered by 21 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yin Zhang | BOCI Research Ltd. |
| Chao Fan | Changjiang Securities Co. LTD. |
| Liang Long | Chasing Securities |